TScan Therapeutics, Inc. (TCRX) Insider Trading -- Recent Executive & Director Transactions
4 insiders reported 12 Form 4 transactions for TScan Therapeutics, Inc. (TCRX) over the past 18 months (most recent 2026-10-02). Recent activity: ZDRAVESKI ZORAN (Chief Legal and Strategy Officer) Buy 300,000 shares, MacBeath Gavin (Chief Executive Officer) Buy 1.0M shares, Nichols Weston (10% Owner) Buy 75,500 shares, Nichols Weston (10% Owner) Buy 80,069 shares, Lynx1 Capital Management LP (10% Owner) Buy 80,069 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | ZDRAVESKI ZORAN | Chief Legal and Strategy Officer | Buy | 300,000 | $0 |
| 2026-10-02 | MacBeath Gavin | Chief Executive Officer | Buy | 1.0M | $0 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 75,500 | $67,950 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 80,069 | $72,062 |
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 80,069 | $72,062 |
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 75,500 | $67,950 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 6,232 | $5,609 |
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 6,232 | $5,609 |
| 2025-05-21 | Nichols Weston | 10% Owner | Buy | 1.4M | $1.7M |
| 2025-05-21 | Lynx1 Capital Management LP | 10% Owner | Buy | 1.4M | $1.7M |
| 2025-05-21 | Nichols Weston | 10% Owner | Buy | 1.2M | $1.4M |
| 2025-05-21 | Lynx1 Capital Management LP | 10% Owner | Buy | 1.2M | $1.4M |
Source: SEC Form 4 filings · as of 2026-10-02